One of the resistance mechanisms to BRAF/MEK inhibitors involves the up-regulation of pro-survival factors, which enable melanoma cells to evade apoptosis even when ERK is completely or efficiently inhibited [21]. The gene discussed is MAP2K7; the disease is melanoma.